Data:
{
"symbol": "KYMR",
"price": 120.65,
"marketCap": 9924377992,
"beta": 1.954,
"lastDividend": 0,
"range": "39.84-130.05",
"change": -4.9,
"changePercentage": -3.90283,
"volume": 369136.7787,
"averageVolume": 747299,
"companyName": "Kymera Therapeutics, Inc.",
"currency": "USD",
"cik": "0001815442",
"isin": "US5015751044",
"cusip": "501575104",
"exchangeFullName": "NASDAQ Global Market",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.kymeratx.com",
"description": "Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.",
"ceo": "Nello Mainolfi",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "273",
"phone": "857 285 5300",
"address": "500 North Beacon Street",
"city": "Watertown",
"state": "MA",
"zip": "02472",
"image": "https://images.financialmodelingprep.com/symbol/KYMR.png",
"ipoDate": "2020-08-21",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "KYMR",
"name": "Kymera Therapeutics, Inc.",
"price": 119.4775,
"changePercentage": 1.12357,
"change": 1.3275,
"volume": 19425,
"dayLow": 116.81,
"dayHigh": 119.86,
"yearHigh": 130.05,
"yearLow": 39.84,
"marketCap": 9827930970,
"priceAvg50": 112.3182,
"priceAvg200": 87.7314,
"exchange": "NASDAQ",
"open": 118.6,
"previousClose": 118.15,
"timestamp": 1788183797,
"chart_vwap_daily": [
{
"t": "2026-07-21",
"v": 112.5194,
"c": 113.37
},
{
"t": "2026-07-22",
"v": 110.8911,
"c": 110.34
},
{
"t": "2026-07-23",
"v": 110.3731,
"c": 110.38
},
{
"t": "2026-07-24",
"v": 110.5509,
"c": 110.57
},
{
"t": "2026-07-27",
"v": 110.7203,
"c": 110.05
},
{
"t": "2026-07-28",
"v": 106.8352,
"c": 106.16
},
{
"t": "2026-07-29",
"v": 105.6336,
"c": 105.25
},
{
"t": "2026-07-30",
"v": 106.4356,
"c": 107.01
},
{
"t": "2026-07-31",
"v": 103.493,
"c": 103.4
},
{
"t": "2026-08-03",
"v": 100.6531,
"c": 100.31
},
{
"t": "2026-08-04",
"v": 103.9902,
"c": 104.39
},
{
"t": "2026-08-05",
"v": 105.3305,
"c": 105.48
},
{
"t": "2026-08-06",
"v": 105.3482,
"c": 106.41
},
{
"t": "2026-08-07",
"v": 106.6496,
"c": 107.52
},
{
"t": "2026-08-10",
"v": 107.8722,
"c": 108.58
},
{
"t": "2026-08-11",
"v": 108.0142,
"c": 109.62
},
{
"t": "2026-08-12",
"v": 113.152,
"c": 114.03
},
{
"t": "2026-08-13",
"v": 114.0077,
"c": 114.42
},
{
"t": "2026-08-14",
"v": 116.3048,
"c": 117.39
},
{
"t": "2026-08-17",
"v": 121.0714,
"c": 121.41
},
{
"t": "2026-08-18",
"v": 120.6005,
"c": 121.38
},
{
"t": "2026-08-19",
"v": 125.3192,
"c": 127.31
},
{
"t": "2026-08-20",
"v": 122.573,
"c": 121.5
},
{
"t": "2026-08-21",
"v": 121.4799,
"c": 119.8
},
{
"t": "2026-08-24",
"v": 119.7144,
"c": 121.05
},
{
"t": "2026-08-25",
"v": 125.8714,
"c": 126.64
},
{
"t": "2026-08-26",
"v": 125.1049,
"c": 125.55
},
{
"t": "2026-08-27",
"v": 121.8647,
"c": 120.23
},
{
"t": "2026-08-28",
"v": 118.4785,
"c": 118.15
},
{
"t": "2026-08-31",
"v": 118.334,
"c": 119.5
}
],
"vwap_summary": {
"days": 30,
"days_above": 20,
"days_below": 10,
"pct_days_above": 67,
"position": "above",
"gap_pct": 0.99,
"streak_days": 1
}
}
Data:
{
"volume": 19425,
"avgVolume": 747299,
"short_ratio": [
{
"symbol": "KYMR",
"file_date": "2026-08-28",
"date": "20260828",
"short_volume": 111806,
"short_exempt_volume": 725,
"total_volume": 180442,
"short_volume_ratio": 0.6196,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 107.9,
"vah": 121.5,
"val": 101.63,
"profile": [
{
"price": 101.85,
"volume": 13269
},
{
"price": 102.28,
"volume": 34682
},
{
"price": 102.71,
"volume": 43696
},
{
"price": 103.15,
"volume": 7890
},
{
"price": 103.58,
"volume": 39981
},
{
"price": 104.01,
"volume": 97939
},
{
"price": 104.44,
"volume": 354376
},
{
"price": 104.87,
"volume": 298931
},
{
"price": 105.3,
"volume": 168039
},
{
"price": 105.74,
"volume": 99568
},
{
"price": 106.17,
"volume": 169775
},
{
"price": 106.6,
"volume": 126939
},
{
"price": 107.03,
"volume": 142528
},
{
"price": 107.46,
"volume": 144013
},
{
"price": 107.9,
"volume": 2076354
},
{
"price": 108.33,
"volume": 102030
},
{
"price": 108.76,
"volume": 102440
},
{
"price": 109.19,
"volume": 6855
},
{
"price": 109.62,
"volume": 98708
},
{
"price": 110.05,
"volume": 28030
},
{
"price": 110.49,
"volume": 11577
},
{
"price": 110.92,
"volume": 17930
},
{
"price": 111.35,
"volume": 16097
},
{
"price": 111.78,
"volume": 98931
},
{
"price": 112.21,
"volume": 77596
},
{
"price": 112.64,
"volume": 139460
},
{
"price": 113.08,
"volume": 132697
},
{
"price": 113.51,
"volume": 119479
},
{
"price": 113.94,
"volume": 292112
},
{
"price": 114.37,
"volume": 210363
},
{
"price": 114.8,
"volume": 47200
},
{
"price": 115.24,
"volume": 13238
},
{
"price": 115.67,
"volume": 33474
},
{
"price": 116.1,
"volume": 18242
},
{
"price": 116.53,
"volume": 22908
},
{
"price": 116.96,
"volume": 49995
},
{
"price": 117.39,
"volume": 119943
},
{
"price": 117.83,
"volume": 88225
},
{
"price": 118.26,
"volume": 116086
},
{
"price": 118.69,
"volume": 281383
},
{
"price": 119.12,
"volume": 116935
},
{
"price": 119.55,
"volume": 109330
},
{
"price": 119.98,
"volume": 218131
},
{
"price": 120.42,
"volume": 207494
},
{
"price": 120.85,
"volume": 245038
},
{
"price": 121.28,
"volume": 445334
},
{
"price": 121.71,
"volume": 245892
},
{
"price": 122.14,
"volume": 194097
},
{
"price": 122.57,
"volume": 219516
},
{
"price": 123.01,
"volume": 172487
},
{
"price": 123.44,
"volume": 190429
},
{
"price": 123.87,
"volume": 216598
},
{
"price": 124.3,
"volume": 363048
},
{
"price": 124.73,
"volume": 229241
},
{
"price": 125.17,
"volume": 293434
},
{
"price": 125.6,
"volume": 165188
},
{
"price": 126.03,
"volume": 58947
},
{
"price": 126.46,
"volume": 210427
},
{
"price": 126.89,
"volume": 198963
},
{
"price": 127.32,
"volume": 157912
}
],
"sessions": 20
}
}
Data:
{
"symbol": "KYMR",
"marketCap": 9829370478,
"enterpriseValueTTM": 9787115478,
"evToSalesTTM": 93.22038954557145,
"evToOperatingCashFlowTTM": -41.33735767564052,
"evToFreeCashFlowTTM": -41.12993779522265,
"evToEBITDATTM": -33.4306220406546,
"netDebtToEBITDATTM": 0.14433373525664456,
"currentRatioTTM": 9.831510868115748,
"incomeQualityTTM": 0.7902577094201956,
"grahamNumberTTM": null,
"grahamNetNetTTM": 5.736792666171901,
"taxBurdenTTM": 0.9992563518556189,
"interestBurdenTTM": 1.0007041266493584,
"workingCapitalTTM": 662275000,
"investedCapitalTTM": 743346000,
"returnOnAssetsTTM": -0.18210890191340454,
"operatingReturnOnAssetsTTM": -0.21130319871110226,
"returnOnTangibleAssetsTTM": -0.18210890191340454,
"returnOnEquityTTM": -0.2150026503121628,
"returnOnInvestedCapitalTTM": -0.2214025359833337,
"returnOnCapitalEmployedTTM": -0.2229788328725324,
"earningsYieldTTM": -0.02554195246489183,
"freeCashFlowYieldTTM": -0.02420867140297446,
"capexToOperatingCashFlowTTM": -0.00504303900119107,
"capexToDepreciationTTM": 0.14502611441758775,
"capexToRevenueTTM": 0.011372619988760727,
"salesGeneralAndAdministrativeToRevenueTTM": 0.7216660793035461,
"researchAndDevelopementToRevenueTTM": 3.577517644705636,
"stockBasedCompensationToRevenueTTM": 0.6210174399222775,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 10000000,
"averagePayablesTTM": 10878500,
"averageInventoryTTM": -2911000,
"daysOfSalesOutstandingTTM": 69.53109373362925,
"daysOfPayablesOutstandingTTM": -1561.9337811900193,
"daysOfInventoryOutstandingTTM": 1019.6880998080615,
"operatingCycleTTM": 1089.2191935416906,
"cashConversionCycleTTM": 2651.15297473171,
"freeCashFlowToEquityTTM": -240077000,
"freeCashFlowToFirmTTM": -237745000,
"tangibleAssetValueTTM": 1505592000,
"netCurrentAssetValueTTM": 597413000,
"grossProfitMarginTTM": 1.019849698539847,
"ebitMarginTTM": -2.854222823343398,
"ebitdaMarginTTM": -2.788473078131995,
"operatingProfitMarginTTM": -3.335377991980112,
"pretaxProfitMarginTTM": -2.8562325576965204,
"continuousOperationsProfitMarginTTM": -2.8562325576965204,
"netProfitMarginTTM": -2.8541085256550685,
"bottomLineProfitMarginTTM": -2.8541085256550685,
"receivablesTurnoverTTM": 5.24945,
"payablesTurnoverTTM": -0.2336846826642745,
"inventoryTurnoverTTM": 0.3579525936104431,
"fixedAssetTurnoverTTM": 1.2950253481516203,
"assetTurnoverTTM": 0.06380587853491215,
"quickRatioTTM": 9.90914788638485,
"solvencyRatioTTM": -2.0932628778994937,
"cashRatioTTM": 1.6599146552873716,
"priceToEarningsRatioTTM": -36.767692307692315,
"priceToEarningsGrowthRatioTTM": -6.613504249498717,
"forwardPriceToEarningsGrowthRatioTTM": -1.2246371569934733,
"priceToEarningsDilutedRatioTTM": -36.767692307692315,
"priceToEarningsDilutedGrowthRatioTTM": -6.613504249498717,
"priceToBookRatioTTM": 7.773154120447427,
"priceToSalesRatioTTM": 93.62286028060083,
"priceToFreeCashFlowRatioTTM": -41.30751264099246,
"priceToOperatingCashFlowRatioTTM": -49.5505169546211,
"debtToAssetsRatioTTM": 0.049969491517183204,
"debtToEquityRatioTTM": 0.05447849801491596,
"debtToCapitalRatioTTM": 0.051663924980426996,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.0902351887287511,
"workingCapitalTurnoverRatioTTM": 0.16442245650961893,
"operatingCashFlowRatioTTM": -3.1572476330177355,
"operatingCashFlowSalesRatioTTM": -2.255112440350894,
"freeCashFlowOperatingCashFlowRatioTTM": 1.005043039001191,
"debtServiceCoverageRatioTTM": -1387.483412322275,
"interestCoverageRatioTTM": -1659.6113744075828,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -2.8795456203935688,
"capitalExpenditureCoverageRatioTTM": -198.29313232830822,
"dividendPaidAndCapexCoverageRatioTTM": -198.29313232830822,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 1.069383165481323,
"netIncomePerShareTTM": -3.0521356097922494,
"interestDebtPerShareTTM": 0.8396352235007658,
"cashPerShareTTM": 7.038144249398623,
"bookValuePerShareTTM": 15.335461228160629,
"tangibleBookValuePerShareTTM": 15.335461228160629,
"shareholdersEquityPerShareTTM": 15.372781518079796,
"operatingCashFlowPerShareTTM": -2.41157927997875,
"capexPerShareTTM": 0.012161688363397115,
"freeCashFlowPerShareTTM": -2.4237409683421474,
"netIncomePerEBTTTM": 0.9992563518556189,
"ebtPerEbitTTM": 0.8563444876605611,
"priceToFairValueTTM": 7.773154120447427,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -33.4306220406546,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 39200000
}
],
"dcf": {
"symbol": "KYMR",
"date": "2026-08-31",
"dcf": 0.1135614325602238,
"Stock Price": 118.15
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "KYMR",
"reportedCurrency": "USD",
"cik": "0001815442",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 07:15:56",
"fiscalYear": "2025",
"period": "FY",
"revenue": 39200000,
"costOfRevenue": 0,
"grossProfit": 39200000,
"researchAndDevelopmentExpenses": 316600000,
"generalAndAdministrativeExpenses": 68200000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 68200000,
"otherExpenses": 3800000,
"operatingExpenses": 388600000,
"costAndExpenses": 388600000,
"netInterestIncome": 37777000,
"interestIncome": 38026000,
"interestExpense": 249000,
"depreciationAndAmortization": 8313000,
"ebitda": -303061000,
"ebit": -311374000,
"nonOperatingIncomeExcludingInterest": -38026000,
"operatingIncome": -349400000,
"totalOtherIncomeExpensesNet": 37777000,
"incomeBeforeTax": -311623000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -311623000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -311400000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -311400000,
"eps": -3.69,
"epsDiluted": -3.69,
"weightedAverageShsOut": 84390243,
"weightedAverageShsOutDil": 84390243
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "KYMR",
"reportedCurrency": "USD",
"cik": "0001815442",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 07:15:56",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 357011000,
"shortTermInvestments": 491265000,
"cashAndShortTermInvestments": 848276000,
"netReceivables": 0,
"accountsReceivables": 0,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 22938000,
"totalCurrentAssets": 871214000,
"propertyPlantEquipmentNet": 85526000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 776958000,
"taxAssets": 0,
"otherNonCurrentAssets": 9113999,
"totalNonCurrentAssets": 871597999,
"otherAssets": 0,
"totalAssets": 1742812000,
"totalPayables": 4014999,
"accountPayables": 4014999,
"otherPayables": 0,
"accruedExpenses": 18311000,
"shortTermDebt": 13756000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 22925000,
"otherCurrentLiabilities": 24205000,
"totalCurrentLiabilities": 83212000,
"longTermDebt": 0,
"capitalLeaseObligationsNonCurrent": 68496000,
"deferredRevenueNonCurrent": 11440000,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 79936000,
"otherLiabilities": 0,
"capitalLeaseObligations": 68496000,
"totalLiabilities": 163148000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 8000,
"retainedEarnings": -1065961000,
"additionalPaidInCapital": 2643817000,
"accumulatedOtherComprehensiveIncomeLoss": 1800000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 1579664000,
"totalEquity": 1579664000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 1742812000,
"totalInvestments": 1268223000,
"totalDebt": 82252000,
"netDebt": -274759000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "KYMR",
"reportedCurrency": "USD",
"cik": "0001815442",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 07:15:56",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -311351000,
"depreciationAndAmortization": 8313000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 59904000,
"changeInWorkingCapital": 15266000,
"accountsReceivables": 947000,
"inventory": 0,
"accountsPayables": -1974000,
"otherWorkingCapital": 16293000,
"otherNonCashItems": -5023000,
"netCashProvidedByOperatingActivities": -232891000,
"investmentsInPropertyPlantAndEquipment": -1449000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -1007628000,
"salesMaturitiesOfInvestments": 479137000,
"otherInvestingActivities": 8879000,
"netCashProvidedByInvestingActivities": -521061000,
"netDebtIssuance": -1494000,
"longTermNetDebtIssuance": -1494000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 992207000,
"netCommonStockIssuance": 992207000,
"commonStockIssuance": 992207000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 990713000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 236761000,
"cashAtEndOfPeriod": 362811000,
"cashAtBeginningOfPeriod": 126050000,
"operatingCashFlow": -232891000,
"capitalExpenditure": -1449000,
"freeCashFlow": -234340000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 119.495,
"rsi": 55.13954144869663,
"sma20": 116.51774999999986,
"sma50": 112.89950000000006,
"sma200": 88.01207500000001,
"adx": 32.93679851085681,
"atr": 5.15,
"atr_pct": 4.31,
"atr_expansion_pct": 18.4,
"di_plus": 33.3,
"di_minus": 16.6,
"high_52w": 127.31,
"low_52w": 40.69,
"structure": {
"ema8": 120.58468258935339,
"ema21": 117.42058071618386,
"ema50": 110.531381330485,
"ema200": 88.99632794181574,
"ema10": 120.23652069179332,
"ema20": 117.6754888821654,
"ema10_slope_pct": 1.39,
"ema20_slope_pct": 2.21,
"trend_dir": "up",
"checks": {
"price_above_all": false,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": true,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 1.8,
"_no_bars": false,
"macd": {
"macd": 3.593,
"signal": 3.811,
"histogram": -0.219
},
"bollinger": {
"mid": 116.52,
"upper": 130.68,
"lower": 102.35,
"width_pct": 24.32
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": true,
"candles_since": 13,
"intraday_support": false
},
"momentum": {
"roc10": -1.6,
"ret_3d": -4.82,
"ret_5d": -1.28,
"roc10_accel": -13.06,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.03,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 2.26,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 90161624.35000001,
"avg_vol": 747299
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 3.0
}
}
}
}
Data:
{
"prior_day": {
"high": 119.5,
"low": 116.81,
"close": 119.5,
"date": "2026-08-31"
},
"woodie_pivots": {
"PP": 118.83,
"R1": 120.84,
"S1": 118.16,
"R2": 121.52,
"S2": 116.14
},
"swing": {
"high_20d": 127.85,
"low_20d": 100.53,
"high_60d": 130.05,
"low_60d": 72.77
},
"orb": {
"high": 119.5,
"low": 116.81,
"date": "2026-08-31"
},
"vwap": 118.32,
"volume_profile": {
"poc": 107.9,
"vah": 121.5,
"val": 101.63,
"sessions": 20
},
"premarket": {
"date": "2026-08-28",
"high": 121,
"low": 120,
"last": 120,
"volume": 1575,
"gap_pct": -0.19,
"path": "06:15 120.84 -> 07:00 120.23 -> 09:25 120.00",
"bars": 3,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-07-28",
"o": 108.775,
"h": 110.36,
"l": 105.45,
"c": 106.16,
"v": 679867.406935
},
{
"d": "2026-07-29",
"o": 105,
"h": 108.28,
"l": 104.12,
"c": 105.25,
"v": 505614.883395
},
{
"d": "2026-07-30",
"o": 105.66,
"h": 107.815,
"l": 104.315,
"c": 107.01,
"v": 444448.322694
},
{
"d": "2026-07-31",
"o": 106.25,
"h": 106.725,
"l": 102.13,
"c": 103.4,
"v": 511843.219943
},
{
"d": "2026-08-03",
"o": 102.77,
"h": 103,
"l": 99.52,
"c": 100.31,
"v": 666797.318171
},
{
"d": "2026-08-04",
"o": 101.75,
"h": 104.95,
"l": 100.53,
"c": 104.39,
"v": 601564.93329
},
{
"d": "2026-08-05",
"o": 104.86,
"h": 107.9,
"l": 103.835,
"c": 105.48,
"v": 586318.217428
},
{
"d": "2026-08-06",
"o": 105,
"h": 107.04,
"l": 103.37,
"c": 106.41,
"v": 510918.58229
},
{
"d": "2026-08-07",
"o": 106.61,
"h": 108.12,
"l": 104.78,
"c": 107.52,
"v": 463574.901831
},
{
"d": "2026-08-10",
"o": 106.63,
"h": 109.05,
"l": 106.035,
"c": 108.58,
"v": 404886.939598
},
{
"d": "2026-08-11",
"o": 108.79,
"h": 110.37,
"l": 106.3,
"c": 109.62,
"v": 2380150.818097
},
{
"d": "2026-08-12",
"o": 110.22,
"h": 115,
"l": 109.085,
"c": 114.03,
"v": 961007.523003
},
{
"d": "2026-08-13",
"o": 114.73,
"h": 114.73,
"l": 112.44,
"c": 114.42,
"v": 481717.735149
},
{
"d": "2026-08-14",
"o": 112.9,
"h": 118.04,
"l": 110.05,
"c": 117.39,
"v": 468580.186964
},
{
"d": "2026-08-17",
"o": 117.39,
"h": 122.59,
"l": 117.04,
"c": 121.41,
"v": 704714.692612
},
{
"d": "2026-08-18",
"o": 119.75,
"h": 122.14,
"l": 118.09,
"c": 121.38,
"v": 640892.886492
},
{
"d": "2026-08-19",
"o": 124.63,
"h": 127.36,
"l": 121.825,
"c": 127.31,
"v": 842927.299336
},
{
"d": "2026-08-20",
"o": 124.95,
"h": 125.45,
"l": 121.13,
"c": 121.5,
"v": 580746.031706
},
{
"d": "2026-08-21",
"o": 122.87,
"h": 125.71,
"l": 119.77,
"c": 119.8,
"v": 503430.158903
},
{
"d": "2026-08-24",
"o": 119.98,
"h": 121.56,
"l": 116.46,
"c": 121.05,
"v": 466859.440438
},
{
"d": "2026-08-25",
"o": 122.64,
"h": 127.85,
"l": 121.6,
"c": 126.64,
"v": 925754.084324
},
{
"d": "2026-08-26",
"o": 126.24,
"h": 126.315,
"l": 123.39,
"c": 125.55,
"v": 558343.09306
},
{
"d": "2026-08-27",
"o": 124.99,
"h": 125.065,
"l": 119.98,
"c": 120.23,
"v": 595695.641225
},
{
"d": "2026-08-28",
"o": 119.4,
"h": 121.975,
"l": 117.48,
"c": 118.15,
"v": 415947.002332
},
{
"d": "2026-08-31",
"o": 118.6,
"h": 119.5,
"l": 116.81,
"c": 119.5,
"v": 18935.804934
}
]
}
Data:
{
"estimates": [
{
"symbol": "KYMR",
"date": "2030-12-31",
"revenueLow": 158458795,
"revenueHigh": 449179421,
"revenueAvg": 298486007,
"ebitdaLow": -586088074,
"ebitdaHigh": -124562050,
"ebitdaAvg": -346858611,
"ebitLow": -603501534,
"ebitHigh": -141975510,
"ebitAvg": -364272071,
"netIncomeLow": -603732868,
"netIncomeHigh": -142206844,
"netIncomeAvg": -364503405,
"sgaExpenseLow": 165588901,
"sgaExpenseHigh": 469390966,
"sgaExpenseAvg": 311916861,
"epsAvg": -4.31926,
"epsHigh": -1.68511,
"epsLow": -7.15406,
"numAnalystsRevenue": 9,
"numAnalystsEps": 13
},
{
"symbol": "KYMR",
"date": "2029-12-31",
"revenueLow": 35098077,
"revenueHigh": 99491695,
"revenueAvg": 66113623,
"ebitdaLow": -784848954,
"ebitdaHigh": -177530343,
"ebitdaAvg": -470048871,
"ebitLow": -794215047,
"ebitHigh": -186896436,
"ebitAvg": -479414964,
"netIncomeLow": -794446381,
"netIncomeHigh": -187127770,
"netIncomeAvg": -479646298,
"sgaExpenseLow": 36677371,
"sgaExpenseHigh": 103968482,
"sgaExpenseAvg": 69088511,
"epsAvg": -5.68367,
"epsHigh": -2.21741,
"epsLow": -9.41396,
"numAnalystsRevenue": 10,
"numAnalystsEps": 13
},
{
"symbol": "KYMR",
"date": "2028-12-31",
"revenueLow": -25000001,
"revenueHigh": 92872076,
"revenueAvg": 40551433,
"ebitdaLow": -524558340,
"ebitdaHigh": -335185788,
"ebitdaAvg": -429872064,
"ebitLow": -533519237,
"ebitHigh": -344146685,
"ebitAvg": -438832961,
"netIncomeLow": -533750571,
"netIncomeHigh": -344378019,
"netIncomeAvg": -439064295,
"sgaExpenseLow": -26124915,
"sgaExpenseHigh": 97051003,
"sgaExpenseAvg": 42376109,
"epsAvg": -5.23099,
"epsHigh": -4.08078,
"epsLow": -6.32479,
"numAnalystsRevenue": 18,
"numAnalystsEps": 16
},
{
"symbol": "KYMR",
"date": "2027-12-31",
"revenueLow": 19037825,
"revenueHigh": 50107556,
"revenueAvg": 41331119,
"ebitdaLow": -515795047,
"ebitdaHigh": -315390159,
"ebitdaAvg": -482652671,
"ebitLow": -525311442,
"ebitHigh": -324906554,
"ebitAvg": -492169066,
"netIncomeLow": -525542776,
"netIncomeHigh": -325137888,
"netIncomeAvg": -492400400,
"sgaExpenseLow": 19894462,
"sgaExpenseHigh": 52362225,
"sgaExpenseAvg": 43190878,
"epsAvg": -4.9367,
"epsHigh": -3.85279,
"epsLow": -6.22753,
"numAnalystsRevenue": 16,
"numAnalystsEps": 17
}
],
"price_target": {
"symbol": "KYMR",
"targetHigh": 170,
"targetLow": 97,
"targetConsensus": 132.82,
"targetMedian": 135
},
"ratings": {
"symbol": "KYMR",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 4,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "KYMR",
"date": "2026-08-06",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-07-28",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-07-16",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-07-13",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Sector Perform",
"action": "downgrade"
},
{
"symbol": "KYMR",
"date": "2026-06-30",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-06-29",
"gradingCompany": "B. Riley Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-06-29",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-06-26",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-06-25",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-03-03",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-03-02",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-03-02",
"gradingCompany": "Stephens & Co.",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-02-26",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-02-26",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-02-03",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-01-28",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-01-15",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2026-01-06",
"gradingCompany": "Wolfe Research",
"previousGrade": "Outperform",
"newGrade": "Peer Perform",
"action": "downgrade"
},
{
"symbol": "KYMR",
"date": "2025-12-22",
"gradingCompany": "B. Riley Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-16",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-11",
"gradingCompany": "Stephens & Co.",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-11",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-10",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-12-09",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-11-26",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-11-05",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-11-05",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-11-05",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-10-22",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-10-17",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-10-01",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-09-30",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "KYMR",
"date": "2025-09-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Guggenheim Maintains Buy on Kymera Therapeutics, Raises Price Target to $170",
"url": "https://www.benzinga.com/news/26/08/61520035/guggenheim-maintains-buy-kymera-therapeutics-raises-price-target-170",
"source": "benzinga",
"date": "2026-08-31T12:59:10.280000+00:00",
"summary": "Guggenheim analyst Brad Canino maintains Kymera Therapeutics (NASDAQ:KYMR) with a Buy and raises the price target from $135 to $170.",
"image": ""
},
{
"title": "KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments",
"url": "https://www.zacks.com/stock/news/2970366/kymr-q2-earnings-and-revenues-top-estimates-on-gilead-sanofi-payments?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2970366",
"source": "Zacks Investment Research",
"date": "2026-08-06 15:56:13",
"summary": "Kymera Therapeutics beat revenue estimates as milestone payments boost results and advances KT-621 development, with key trial data expected by year-end.",
"image": "https://images.financialmodelingprep.com/news/kymr-q2-earnings-and-revenues-top-estimates-on-gilead-20260806.jpg"
},
{
"title": "Kymera Therapeutics, Inc. (KYMR) Q2 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4931150-kymera-therapeutics-inc-kymr-q2-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-08-05 15:40:11",
"summary": "Kymera Therapeutics, Inc. (KYMR) Q2 2026 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-inc-kymr-q2-2026-earnings-call-transcript-20260805.jpg"
},
{
"title": "Kymera Therapeutics Q2 Earnings Call Highlights",
"url": "https://www.marketbeat.com/instant-alerts/kymera-therapeutics-q2-earnings-call-highlights-2026-08-05/",
"source": "MarketBeat",
"date": "2026-08-05 13:06:04",
"summary": "Kymera Therapeutics NASDAQ: KYMR said it completed enrollment in its Phase 2b atopic dermatitis trial of KT-621 about six months ahead of schedule, positioning the company to report top-line data by the end of 2026 and potentially begin Phase 3 development around mid-2027.",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-q2-earnings-call-highlights-20260805.jpg"
},
{
"title": "Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates",
"url": "https://www.zacks.com/stock/news/2968327/kymera-therapeutics-inc-kymr-reports-q2-loss-tops-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2968327",
"source": "Zacks Investment Research",
"date": "2026-08-05 09:16:14",
"summary": "Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $0.95 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-inc-kymr-reports-q2-loss-tops-revenue-20260805.jpg"
},
{
"title": "Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update",
"url": "https://www.globenewswire.com/news-release/2026/08/05/3339183/0/en/kymera-therapeutics-announces-second-quarter-2026-financial-results-and-provides-a-business-update.html",
"source": "GlobeNewsWire",
"date": "2026-08-05 07:00:00",
"summary": "Enrollment completed in KT-621 (STAT6) BROADEN2 Phase 2b AD trial nearly six months ahead of anticipated timeline, with data expected by year-end 2026 KT-621 Phase 3 trials in AD planned to initiate by mid-2027 KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to b",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-announces-second-quarter-2026-financial-results-and-20260805.jpg"
},
{
"title": "Here Are Wednesday\u2019s Top Wall Street Analyst Research Calls: Bloom Energy, Dave, Fiverr, Humana, Las Vegas Sands, Lemonade, Procter & Gamble, SK hynix, Wix.com, and More",
"url": "https://247wallst.com/investing/2026/07/30/here-are-wednesdays-top-wall-street-analyst-research-calls-bloom-energy-dave-fiverr-humana-las-vegas-sands-lemonade-procter-gamble-sk-hynix-wix-com-and-more/",
"source": "247 Wallst",
"date": "2026-07-30 08:05:16",
"summary": "Wall Street analysts reshuffled their bets on Thursday as geopolitical fires, a Fed dissent surprise, and a brutal semiconductor selloff forced some major rating reversals across insurance, gaming, tech, and energy stocks.",
"image": "https://images.financialmodelingprep.com/news/here-are-wednesdays-top-wall-street-analyst-research-calls-20260730.jpg"
},
{
"title": "Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026",
"url": "https://www.globenewswire.com/news-release/2026/07/28/3334688/0/en/Kymera-Therapeutics-to-Report-Second-Quarter-2026-Financial-Results-on-August-5-2026.html",
"source": "GlobeNewsWire",
"date": "2026-07-28 16:01:00",
"summary": "WATERTOWN, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report second quarter 2026 financial results o",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-to-report-second-quarter-2026-financial-results-20260728.jpg"
},
{
"title": "Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer",
"url": "https://www.globenewswire.com/news-release/2026/07/27/3333847/0/en/kymera-therapeutics-appoints-terence-rooney-md-as-chief-medical-officer.html",
"source": "GlobeNewsWire",
"date": "2026-07-27 16:01:00",
"summary": "Dr. Rooney, former immunology leader at Johnson & Johnson, will lead clinical development strategy across Kymera's industry-leading oral immunology portfolio Jared Gollob, MD, will retire from his role after eight years of leadership at the Company WATERTOWN, Mass., July 27, 2026",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-appoints-terence-rooney-md-as-chief-medical-20260727.jpg"
},
{
"title": "Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm",
"url": "https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-kymera-therapeutics-inc-to-contact-law-firm-302834805.html",
"source": "PRNewsWire",
"date": "2026-07-27 08:49:00",
"summary": "NEW YORK, July 27, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Kymera Therapeutics, Inc. (NASDAQ: KYMR) breached their fiduciary duties to shareholders. The investigation concerns potential se",
"image": "https://images.financialmodelingprep.com/news/kuehn-law-encourages-investors-of-kymera-therapeutics-inc-to-20260727.jpg"
},
{
"title": "Kymera Therapeutics (NASDAQ:KYMR) Shares Gap Up \u2013 Here\u2019s Why",
"url": "https://www.defenseworld.net/2026/07/26/kymera-therapeutics-nasdaqkymr-shares-gap-up-heres-why.html",
"source": "Defense World",
"date": "2026-07-26 02:02:44",
"summary": "Kymera Therapeutics, Inc. (NASDAQ: KYMR - Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $110.38, but opened at $114.15. Kymera Therapeutics shares last traded at $109.1780, with a volume of 25,211 shares traded. Analyst Ratings ",
"image": "https://images.financialmodelingprep.com/news/kymera-therapeutics-nasdaqkymr-shares-gap-up-heres-why-20260726.png"
},
{
"title": "Is Kymera Therapeutics Poised for a Breakthrough With KT-621?",
"url": "https://www.zacks.com/stock/news/2960407/is-kymera-therapeutics-poised-for-a-breakthrough-with-kt-621?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2960407",
"source": "Zacks Investment Research",
"date": "2026-07-24 12:21:09",
"summary": "Kymera Therapeutics advances KT-621 enrollment ahead of schedule, bringing pivotal atopic dermatitis data closer as it expands its protein degrader pipeline.",
"image": "https://images.financialmodelingprep.com/news/is-kymera-therapeutics-poised-for-a-breakthrough-with-kt621-20260724.jpg"
},
{
"title": "SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)",
"url": "https://www.gurufocus.com/news/8963022/shareholder-alert-purcell-lefkowitz-llp-announces-shareholder-investigation-of-kymera-therapeutics-inc-nasdaq-kymr",
"source": "GuruFocus",
"date": "2026-07-16 12:00:00",
"summary": "SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR) PR N",
"image": "https://images.financialmodelingprep.com/news/shareholder-alert-purcell-lefkowitz-llp-announces-shareholder-investigation-of-kymera-therapeutics-20260716.png"
},
{
"title": "Kymera's CEO Sold $6 Million in Stock After a 170% Run",
"url": "https://www.fool.com/coverage/filings/2026/07/12/kymera-s-ceo-sold-usd6-million-in-stock-after-a-170-run/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-07-12T20:37:46Z",
"summary": "Kymera Therapeutics CEO Nello Mainolfi sold 50,000 shares for $6 million on July 7, 2026, following a 170% stock surge over 12 months. The sale involved exercising options at $2.08 and selling at $119 per share under a pre-scheduled Rule 10b5-1 trading plan. Despite the sale, Mai",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting",
"url": "https://www.globenewswire.com/news-release/2026/06/12/3310977/0/en/Kymera-Therapeutics-Presents-Phase-1-Data-in-Healthy-Japanese-Adults-for-KT-621-a-First-in-Class-Oral-STAT6-Degrader-at-the-Japanese-Dermatological-Association-Annual-Meeting.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-12T11:00:00Z",
"summary": "Kymera Therapeutics announced Phase 1 results for KT-621, a first-in-class oral STAT6 degrader, in healthy Japanese adults at the Japanese Dermatological Association Annual Meeting. The data showed consistent safety and pharmacokinetic/pharmacodynamic profiles with previous studi",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
},
{
"title": "Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses",
"url": "https://www.globenewswire.com/news-release/2026/06/08/3307932/0/en/Kymera-Therapeutics-Presents-New-Preclinical-Lupus-Data-for-KT-579-First-in-Class-Oral-IRF5-Degrader-at-EULAR-and-FOCIS-Congresses.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-08T11:00:00Z",
"summary": "Kymera Therapeutics announced preclinical data for KT-579, an oral IRF5 degrader, demonstrating disease-modifying activity in lupus models comparable or superior to approved therapies. The compound showed consistent activity across multiple disease pathways including Type I inter",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
},
{
"title": "Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses",
"url": "https://www.globenewswire.com/news-release/2026/05/15/3295720/0/en/Kymera-Therapeutics-Announces-Presentations-on-KT-621-a-First-In-Class-Oral-STAT6-Degrader-at-the-Society-for-Investigative-Dermatology-and-American-Thoracic-Society-Congresses.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-15T11:00:00Z",
"summary": "Kymera Therapeutics announced presentations of Phase 1b clinical data for KT-621, its first-in-class oral STAT6 degrader, at the Society for Investigative Dermatology and American Thoracic Society congresses. The data demonstrated deep STAT6 degradation in blood and skin, reducti",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
},
{
"title": "Kymera Therapeutics to Participate in Upcoming May Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/05/06/3288646/0/en/Kymera-Therapeutics-to-Participate-in-Upcoming-May-Investor-Conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-06T11:00:00Z",
"summary": "Kymera Therapeutics announced participation in upcoming investor conferences in May 2026 and presented preclinical data for KT-579, its first-in-class oral IRF5 degrader for inflammatory bowel disease, showing activity comparable or superior to approved therapies. The company has",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
},
{
"title": "Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026",
"url": "https://www.globenewswire.com/news-release/2026/04/23/3279714/0/en/Kymera-Therapeutics-to-Report-First-Quarter-2026-Financial-Results-on-April-30-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-23T11:00:00Z",
"summary": "Kymera Therapeutics will report Q1 2026 financial results on April 30, 2026. The company announced FDA Fast Track designation for KT-621, a first-in-class oral STAT6 degrader for moderate to severe asthma, with Phase 2b trial data expected in late 2027. Additionally, Gilead Scien",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
},
{
"title": "Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit",
"url": "https://www.fool.com/coverage/filings/2026/02/25/protagonist-stock-up-120-but-one-fund-just-revealed-a-usd170-million-exit/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-02-25T20:28:39Z",
"summary": "Hedge fund BVF fully exited its position in Protagonist Therapeutics (PTGX), selling 2.56 million shares worth $170.12 million. Despite the stock rallying 120% over the past year, the fund's exit reflects a disciplined capital rotation strategy following the company's New Drug Ap",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png%3Frect%3D76%2C0%2C1251%2C1251%26w%3D384%26h%3D384%26q%3D75%26fit%3Dcrop%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction",
"url": "https://www.fool.com/coverage/filings/2026/02/25/disc-medicine-stock-is-swinging-but-this-fund-s-new-usd52-million-bet-shows-conviction/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-02-25T20:19:41Z",
"summary": "Hedge fund BVF invested $52 million in Disc Medicine (IRON) by acquiring 650,000 shares in Q4, demonstrating conviction in the clinical-stage biotech company despite recent FDA setbacks. The investment was made before the FDA's Complete Response Letter in February and a subsequen",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2Fc1631655103f7157a9e8d36ebaec7d6a2cfb7675-1401x1251.png%3Frect%3D76%2C0%2C1251%2C1251%26w%3D384%26h%3D384%26q%3D75%26fit%3Dcrop%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs",
"url": "https://www.globenewswire.com/news-release/2026/01/13/3217633/0/en/Kymera-Therapeutics-Outlines-Key-2026-Objectives-and-Strategy-to-Advance-Industry-Leading-Portfolio-of-Oral-Immunology-Programs.html",
"source": "GlobeNewswire Inc.",
"date": "2026-01-13T12:00:00Z",
"summary": "Kymera Therapeutics announced its 2026 clinical and preclinical milestones, including ongoing Phase 2b trials for KT-621 in atopic dermatitis and asthma with data expected in 2027, initiation of Phase 1 testing for KT-579 in Q1 2026, and advancement of at least one new developmen",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
},
{
"title": "Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks",
"url": "https://www.investing.com/analysis/insider-buying-smart-money-just-spent-100m-on-these-3-stocks-200672626",
"source": "Investing.com",
"date": "2026-01-02T17:30:00Z",
"summary": "Three stocks have attracted over $100 million in insider buying from prominent institutional investors: DoorDash (Sequoia Capital), Kenvue (Starboard Value LP), and Kymera Therapeutics (Baker Bros. Advisors). While these purchases signal confidence from sophisticated capital, inv",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investingcom_analysis_og.jpg"
},
{
"title": "Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares",
"url": "https://www.benzinga.com/pressreleases/25/12/g49347921/kymera-therapeutics-announces-closing-of-upsized-602-million-public-offering-and-full-exercise-of-?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2025-12-11T21:01:00Z",
"summary": "Kymera Therapeutics successfully closed a public offering of $602 million, selling 8,050,000 shares at $86.00 per share, including the full exercise of underwriters' option to purchase additional shares.",
"image": "https://www.benzinga.com/next-assets/images/benzinga-schema-image-default.png"
},
{
"title": "Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering",
"url": "https://www.globenewswire.com/news-release/2025/12/10/3202895/0/en/Kymera-Therapeutics-Announces-Pricing-of-Upsized-602-Million-Public-Offering.html",
"source": "GlobeNewswire Inc.",
"date": "2025-12-10T04:30:00Z",
"summary": "Kymera Therapeutics plans to raise $602 million through a public offering of 7 million common stock shares at $86 per share, with proceeds intended to advance its preclinical and clinical degrader programs.",
"image": "https://ml.globenewswire.com/Resource/Download/4d3d3283-c57d-401e-9e1b-53f17e22d76b"
}
]
Data:
[
{
"symbol": "KYMR",
"date": "2026-11-03",
"epsActual": null,
"epsEstimated": -1.25,
"revenueActual": null,
"revenueEstimated": 3823110,
"lastUpdated": "2026-08-31"
},
{
"symbol": "KYMR",
"date": "2026-08-05",
"epsActual": -0.62,
"epsEstimated": -0.7126,
"revenueActual": 65000000,
"revenueEstimated": 32775520,
"lastUpdated": "2026-08-31"
},
{
"symbol": "KYMR",
"date": "2026-04-30",
"epsActual": -0.71,
"epsEstimated": -0.89,
"revenueActual": 34365000,
"revenueEstimated": 8266582,
"lastUpdated": "2026-07-31"
},
{
"symbol": "KYMR",
"date": "2026-02-26",
"epsActual": -0.97,
"epsEstimated": -0.78366,
"revenueActual": 2871000,
"revenueEstimated": 15047880,
"lastUpdated": "2026-05-26"
},
{
"symbol": "KYMR",
"date": "2025-11-04",
"epsActual": -0.9,
"epsEstimated": -0.71,
"revenueActual": 2764000,
"revenueEstimated": 14452270,
"lastUpdated": "2026-02-04"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "KYMR",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "KYMR",
"periods": [
{
"file_period": "202604b",
"settlement_date": "20260422",
"quantity_fails": 792,
"price": 88.07
},
{
"file_period": "202606a",
"settlement_date": "20260608",
"quantity_fails": 2356,
"price": 74.13
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 211145,
"price": 109.32
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 311,
"price": 110.4
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 1482,
"price": 107.01
},
{
"file_period": "202608a",
"settlement_date": "20260813",
"quantity_fails": 751,
"price": 114.03
}
],
"trend": "stable",
"trend_description": "FTD quantity stable"
}
}
Data:
{
"insider": [
{
"symbol": "KYMR",
"filingDate": "2026-07-27",
"transactionDate": "2026-07-27",
"reportingCik": "0002146464",
"companyCik": "0001815442",
"transactionType": "A-Award",
"securitiesOwned": 76000,
"reportingName": "Rooney Terence",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 76000,
"price": 110.05,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526318408/0001193125-26-318408-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-27",
"transactionDate": "2026-07-27",
"reportingCik": "0002146464",
"companyCik": "0001815442",
"transactionType": "A-Award",
"securitiesOwned": 38000,
"reportingName": "Rooney Terence",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 38000,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526318408/0001193125-26-318408-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-27",
"transactionDate": "2026-07-27",
"reportingCik": "0002146464",
"companyCik": "0001815442",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Rooney Terence",
"typeOfOwner": "",
"acquisitionOrDisposition": "",
"directOrIndirect": null,
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526318404/0001193125-26-318404-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-07",
"transactionDate": "2026-07-07",
"reportingCik": "0001821189",
"companyCik": "0001815442",
"transactionType": "M-Exempt",
"securitiesOwned": 716568,
"reportingName": "Mainolfi Nello",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 50000,
"price": 2.08,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526297817/0001193125-26-297817-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-07",
"transactionDate": "2026-07-07",
"reportingCik": "0001821189",
"companyCik": "0001815442",
"transactionType": "S-Sale",
"securitiesOwned": 666568,
"reportingName": "Mainolfi Nello",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 50000,
"price": 119,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526297817/0001193125-26-297817-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-07",
"transactionDate": "2026-07-07",
"reportingCik": "0001821189",
"companyCik": "0001815442",
"transactionType": "M-Exempt",
"securitiesOwned": 90000,
"reportingName": "Mainolfi Nello",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 45559,
"price": 2.08,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526297817/0001193125-26-297817-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-07",
"transactionDate": "2026-07-07",
"reportingCik": "0001821189",
"companyCik": "0001815442",
"transactionType": "M-Exempt",
"securitiesOwned": 14284,
"reportingName": "Mainolfi Nello",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4441,
"price": 2.08,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526297817/0001193125-26-297817-index.htm"
},
{
"symbol": "KYMR",
"filingDate": "2026-07-02",
"transactionDate": "2026-06-30",
"reportingCik": "0001821074",
"companyCik": "0001815442",
"transactionType": "M-Exempt",
"securitiesOwned": 321992,
"reportingName": "Jacobs Bruce N.",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 61378,
"price": 5.33,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1815442/000119312526295090/0001193125-26-295090-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:35:02.132000Z",
"size": 1100.0,
"price": 117.1251,
"premium": 128837.61,
"volume": 1100.0,
"trade_code": " "
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:30:00.850000Z",
"size": 924.0,
"price": 118.6,
"premium": 109586.4,
"volume": 924.0,
"trade_code": "O"
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:30:00.850000Z",
"size": 491.0,
"price": 118.6,
"premium": 58232.6,
"volume": 491.0,
"trade_code": "O"
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:30:00.850000Z",
"size": 439.0,
"price": 118.6,
"premium": 52065.399999999994,
"volume": 439.0,
"trade_code": "O"
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:30:00.850000Z",
"size": 414.0,
"price": 118.6,
"premium": 49100.399999999994,
"volume": 414.0,
"trade_code": "O"
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:30:00.850000Z",
"size": 299.0,
"price": 118.6,
"premium": 35461.4,
"volume": 299.0,
"trade_code": "O"
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:35:02.948000Z",
"size": 252.0,
"price": 117.136,
"premium": 29518.271999999997,
"volume": 252.0,
"trade_code": " "
},
{
"ticker": "KYMR",
"executed_at": "2026-08-31T13:30:00.850000Z",
"size": 251.0,
"price": 118.6,
"premium": 29768.6,
"volume": 251.0,
"trade_code": "O"
}
],
"ats": {
"symbol": "KYMR",
"date": "20260828",
"ats_volume": 0,
"total_volume": 180442,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260828",
"ats_ratio": 0.0
},
{
"date": "20260827",
"ats_ratio": 0.0
},
{
"date": "20260826",
"ats_ratio": 0.0
},
{
"date": "20260825",
"ats_ratio": 0.0
},
{
"date": "20260824",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "KYMR",
"days": [
{
"date": "2026-08-31",
"close": 119.5,
"vwap": 118.33,
"volume": 18935,
"vwap_discount_pct": -0.98
},
{
"date": "2026-08-28",
"close": 118.15,
"vwap": 118.48,
"volume": 415947,
"vwap_discount_pct": 0.28
},
{
"date": "2026-08-27",
"close": 120.23,
"vwap": 121.86,
"volume": 595695,
"vwap_discount_pct": 1.36
},
{
"date": "2026-08-26",
"close": 125.55,
"vwap": 125.1,
"volume": 558343,
"vwap_discount_pct": -0.35
},
{
"date": "2026-08-25",
"close": 126.64,
"vwap": 125.87,
"volume": 925754,
"vwap_discount_pct": -0.61
}
],
"avg_vwap_discount_pct": -0.06,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "KYMR",
"net_call_premium": "-120.00",
"net_put_premium": "680.00",
"call_premium": "120.00",
"put_premium": "680.00",
"bullish_premium": "0",
"bearish_premium": "800.00",
"put_call_ratio": "3.0000000000000000",
"iv_rank": "2.5136",
"implied_move_perc": "0.088000",
"gex_ratio": "0.39928486203800723389",
"gex_net_change": "-34.0262",
"gex_call": "4266.0300",
"gex_put": "-1703.3612",
"gex_net": 2562.6688,
"gex_call_delta": "305131.2863",
"gex_put_delta": "-86694.7962",
"gex_date": "2026-08-31"
},
"hot_chains": [
{
"underlying_symbol": "KYMR",
"expires": "2026-11-20",
"open_interest": 5,
"option_type": "put",
"delta": -0.0803826499313696,
"ask_volume": 2,
"last_price": "2.10",
"implied_volatility": "0.925829666994338",
"gamma": 0.0027499160374998,
"avg_price": "2.1000",
"bid_volume": 0,
"nbbo_ask": "5.10",
"strike": "70",
"option_symbol": "KYMR261120P00070000",
"total_premium": "420.00",
"iv": 0.962761227621462,
"volume": 2,
"nbbo_bid": "0.10"
},
{
"underlying_symbol": "KYMR",
"expires": "2026-11-20",
"open_interest": 32,
"option_type": "put",
"delta": -0.0968356110140139,
"ask_volume": 1,
"last_price": "2.60",
"implied_volatility": "0.890893962132234",
"gamma": 0.00335106874120142,
"avg_price": "2.60",
"bid_volume": 0,
"nbbo_ask": "5.30",
"strike": "75",
"option_symbol": "KYMR261120P00075000",
"total_premium": "260.00",
"iv": 0.907659469811492,
"volume": 1,
"nbbo_bid": "0.90"
},
{
"underlying_symbol": "KYMR",
"expires": "2026-09-18",
"open_interest": 21,
"option_type": "call",
"delta": 0.27709940340242,
"ask_volume": 0,
"last_price": "1.20",
"implied_volatility": "0.4437811831603372",
"gamma": 0.02165661184376806,
"avg_price": "1.20",
"bid_volume": 1,
"nbbo_ask": "5.10",
"strike": "130",
"option_symbol": "KYMR260918C00130000",
"total_premium": "120.00",
"iv": 0.57901485896968,
"volume": 1,
"nbbo_bid": "0.15"
},
{
"underlying_symbol": "KYMR",
"expires": "2026-11-20",
"open_interest": 1008,
"option_type": "call",
"delta": 0.497057625256183,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.01131458715656449,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "125",
"option_symbol": "KYMR261120C00125000",
"total_premium": "0",
"iv": 0.625631909371536,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "KYMR",
"expires": "2026-11-20",
"open_interest": 1008,
"option_type": "call",
"delta": 0.334524664671867,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.01087868244154783,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "140",
"option_symbol": "KYMR261120C00140000",
"total_premium": "0",
"iv": 0.593904759169923,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "KYMR",
"expires": "2027-03-19",
"open_interest": 600,
"option_type": "put",
"delta": -0.1450883000959712,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.00229363215904861,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "70",
"option_symbol": "KYMR270319P00070000",
"total_premium": "0",
"iv": 1.123975783308717,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "KYMR",
"expires": "2026-12-18",
"open_interest": 512,
"option_type": "put",
"delta": -0.274739891052382,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.00424641197696491,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "100",
"option_symbol": "KYMR261218P00100000",
"total_premium": "0",
"iv": 1.20196579398693,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "KYMR",
"expires": "2026-12-18",
"open_interest": 511,
"option_type": "put",
"delta": -0.01662552944461619,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.000433783450911832,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "30",
"option_symbol": "KYMR261218P00030000",
"total_premium": "0",
"iv": 1.459311396340972,
"volume": 0,
"nbbo_bid": null
}
],
"gamma_profile": {
"ticker": "KYMR",
"spot": 119.4775,
"date": "2026-08-31",
"flip_point": 124.52,
"net_gex": 2562.67,
"call_walls": [
{
"strike": 140.0,
"gex": 1171.62
},
{
"strike": 125.0,
"gex": 1078.57
},
{
"strike": 145.0,
"gex": 864.35
}
],
"put_walls": [
{
"strike": 100.0,
"gex": -295.1
},
{
"strike": 105.0,
"gex": -248.39
},
{
"strike": 115.0,
"gex": -245.77
}
],
"by_strike": [
{
"strike": 60.0,
"call_gex": 0.2,
"put_gex": -1.97,
"net_gex": -1.78
},
{
"strike": 65.0,
"call_gex": 0.43,
"put_gex": -0.92,
"net_gex": -0.48
},
{
"strike": 70.0,
"call_gex": 1.74,
"put_gex": -163.19,
"net_gex": -161.45
},
{
"strike": 75.0,
"call_gex": 1.07,
"put_gex": -162.45,
"net_gex": -161.38
},
{
"strike": 80.0,
"call_gex": 28.68,
"put_gex": -16.37,
"net_gex": 12.31
},
{
"strike": 85.0,
"call_gex": 17.94,
"put_gex": -20.51,
"net_gex": -2.58
},
{
"strike": 90.0,
"call_gex": 23.76,
"put_gex": -212.59,
"net_gex": -188.83
},
{
"strike": 95.0,
"call_gex": 4.62,
"put_gex": -188.63,
"net_gex": -184.01
},
{
"strike": 100.0,
"call_gex": 82.26,
"put_gex": -295.1,
"net_gex": -212.84
},
{
"strike": 105.0,
"call_gex": 90.29,
"put_gex": -248.39,
"net_gex": -158.1
},
{
"strike": 110.0,
"call_gex": 116.13,
"put_gex": -19.78,
"net_gex": 96.35
},
{
"strike": 115.0,
"call_gex": 60.89,
"put_gex": -245.77,
"net_gex": -184.89
},
{
"strike": 120.0,
"call_gex": 230.1,
"put_gex": -31.46,
"net_gex": 198.65
},
{
"strike": 125.0,
"call_gex": 1078.57,
"put_gex": -0.69,
"net_gex": 1077.88
},
{
"strike": 130.0,
"call_gex": 415.0,
"put_gex": -2.06,
"net_gex": 412.94
},
{
"strike": 135.0,
"call_gex": 41.36,
"put_gex": -3.04,
"net_gex": 38.32
},
{
"strike": 140.0,
"call_gex": 1171.62,
"put_gex": 0.0,
"net_gex": 1171.62
},
{
"strike": 145.0,
"call_gex": 864.35,
"put_gex": -6.28,
"net_gex": 858.07
},
{
"strike": 150.0,
"call_gex": 8.23,
"put_gex": -33.47,
"net_gex": -25.24
},
{
"strike": 155.0,
"call_gex": 3.63,
"put_gex": 0.0,
"net_gex": 3.63
},
{
"strike": 160.0,
"call_gex": 3.28,
"put_gex": -23.77,
"net_gex": -20.49
},
{
"strike": 165.0,
"call_gex": 0.93,
"put_gex": 0.0,
"net_gex": 0.93
},
{
"strike": 170.0,
"call_gex": 5.49,
"put_gex": 0.0,
"net_gex": 5.49
},
{
"strike": 175.0,
"call_gex": 8.74,
"put_gex": 0.0,
"net_gex": 8.74
},
{
"strike": 180.0,
"call_gex": 0.76,
"put_gex": 0.0,
"net_gex": 0.76
}
]
},
"oi_changes": {
"net_call_oi_change": 0,
"net_put_oi_change": 0,
"top": [
{
"strike": "125",
"oi_change": 0,
"type": "call"
},
{
"strike": "140",
"oi_change": 0,
"type": "call"
},
{
"strike": "70",
"oi_change": 0,
"type": "put"
},
{
"strike": "100",
"oi_change": 0,
"type": "put"
},
{
"strike": "30",
"oi_change": 0,
"type": "put"
}
]
}
}
Data:
{
"vix": 15.21,
"sp500": 7675.7,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.47,
"hy_spread": 2.7,
"treasury": {
"date": "2026-08-28",
"month1": 3.84,
"month2": 3.86,
"month3": 3.9,
"month6": 4.02,
"year1": 4.15,
"year2": 4.34,
"year3": 4.41,
"year5": 4.48,
"year7": 4.59,
"year10": 4.73,
"year20": 5.21,
"year30": 5.22
},
"events": [
{
"title": "ISM Manufacturing PMI",
"currency": "USD",
"date": "2026-09-01",
"time_utc": "14:00",
"impact": "High",
"forecast": "55.2",
"previous": "55.6",
"actual": null,
"minutes_until": 1510
}
]
}
Data:
{
"days": 102,
"patterns": [
{
"name": "VWAP Touch",
"count": 102,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 97,
"pct": 95
},
{
"name": "Woodie Pivot Touch",
"count": 97,
"pct": 95
},
{
"name": "PDH/PDL Touch",
"count": 87,
"pct": 85
},
{
"name": "Open Retracement",
"count": 80,
"pct": 78
},
{
"name": "Gap Fill",
"count": 72,
"pct": 71
},
{
"name": "Darvas Box",
"count": 34,
"pct": 33
},
{
"name": "High Vol Open",
"count": 26,
"pct": 25
},
{
"name": "Power Hour",
"count": 12,
"pct": 12
}
]
}